✦ LIBER ✦

Intraperitoneal Interferon-α in Residual Ovarian Carcinoma: A Phase II Gynecologic Oncology Group Study

✍ Scribed by Jonathan S. Berek; Maurie Markman; Bette Stonebraker; Samuel S. Lentz; Mark D. Adelson; Koen DeGeest; David Moore

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intraperitoneal α-Interferon Alternating

✍ Jonathan S. Berek; Maurie Markman; John A. Blessing; Paul R. Kucera; Beth E. Nel 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 45 KB

A Phase II Study of Intraperitoneal Cisp

✍ Lynn G. Feun; John A. Blessing; Francis J. Major; Philip J. DiSaia; Ronald D. Al 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Intraperitoneal Administration of Cispla

✍ Patricia S. Braly; Jonathan S. Berek; John A. Blessing; Howard D. Homesley; Herv 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 322 KB

A phase II study of docetaxel in paclita

✍ Peter G Rose; John A Blessing; Harrison G Ball; James Hoffman; David Warshal; Ko 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Phase II Trial of CI-958 in Recurrent Pl

✍ Mark A. Hoffman; John A. Blessing; Mark Morgan 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 34 KB

A Phase II Trial of CI-958 in Recurrent

✍ Mark A. Hoffman; John A. Blessing; Evelyn R. Nuñez 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 34 KB